Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
| Author | |
|---|---|
| Abstract |
:
Community-acquired pneumonia (CAP) is a major cause of death worldwide and occurs with variable severity. There are few studies focused on the expression of soluble urokinase-type plasminogen activator receptor (suPAR) and syndecan-4 in patients with CAP. |
| Year of Publication |
:
2018
|
| Journal |
:
Critical care (London, England)
|
| Volume |
:
22
|
| Issue |
:
1
|
| Number of Pages |
:
15
|
| Date Published |
:
2018
|
| ISSN Number |
:
1364-8535
|
| URL |
:
https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-1943-y
|
| DOI |
:
10.1186/s13054-018-1943-y
|
| Short Title |
:
Crit Care
|
| Download citation |
